Kremer LCM - Search Results

1

Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study.

de Beijer IAE, Hardijzer EC, Haupt R, Grabow D, Balaguer J, Bardi E, Nieto AC, Ciesiūniene A, Düster V, Filbert AL, Gsell H, Kapitančukė M, Ladenstein R, Langer T, Muraca M, van den Oever SR, Prikken S, Rascon J, Tormo MT, Uyttebroeck A, Vercruysse G, van der Pal HJH, Kremer LCM, Pluijm SMF; PanCareSurPass consortium. de Beijer IAE, et al. Among authors: kremer lcm. J Cancer Surviv. 2024 Mar 11. doi: 10.1007/s11764-024-01547-w. Online ahead of print. J Cancer Surviv. 2024. PMID: 38466480 No abstract available.

2

Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review.

van der Pal HJ, van Dalen EC, Kremer LC, Bakker PJ, van Leeuwen FE. van der Pal HJ, et al. Cancer Treat Rev. 2005 May;31(3):173-85. doi: 10.1016/j.ctrv.2005.03.008. Cancer Treat Rev. 2005. PMID: 15896910 Review.

3

Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.

van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC. van Dalen EC, et al. Eur J Cancer. 2006 Oct;42(15):2549-53. doi: 10.1016/j.ejca.2006.04.014. Epub 2006 Aug 17. Eur J Cancer. 2006. PMID: 16919450

4

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.

van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC. van Dalen EC, et al. Eur J Cancer. 2006 Dec;42(18):3191-8. doi: 10.1016/j.ejca.2006.08.005. Epub 2006 Sep 20. Eur J Cancer. 2006. PMID: 16987655

5

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy.

van Dalen EC, van der Pal HJ, Caron HN, Kremer LC. van Dalen EC, et al. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005008. doi: 10.1002/14651858.CD005008.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2016 Mar 03;3:CD005008. doi: 10.1002/14651858.CD005008.pub4. PMID: 19821337 Updated. Review.

6

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.

Mulder RL, Paulides M, Langer T, Kremer LC, van Dalen EC. Mulder RL, et al. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006300. doi: 10.1002/14651858.CD006300.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2012 Dec 12;12:CD006300. doi: 10.1002/14651858.CD006300.pub3. PMID: 20166081 Updated. Review.

7

Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer.

Mulder RL, Thönissen NM, van der Pal HJ, Bresser P, Hanselaar W, Koning CC, Oldenburger F, Heij HA, Caron HN, Kremer LC. Mulder RL, et al. Thorax. 2011 Dec;66(12):1065-71. doi: 10.1136/thoraxjnl-2011-200618. Epub 2011 Jul 29. Thorax. 2011. PMID: 21803931

8

Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors.

Mulder RL, Kremer LC, Koot BG, Benninga MA, Knijnenburg SL, van der Pal HJ, Koning CC, Oldenburger F, Wilde JC, Taminiau JA, Caron HN, van Dalen EC. Mulder RL, et al. Eur J Cancer. 2013 Jan;49(1):185-93. doi: 10.1016/j.ejca.2012.07.009. Epub 2012 Aug 15. Eur J Cancer. 2013. PMID: 22901831

9

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients.

Mulder RL, Paulides M, Langer T, Kremer LC, van Dalen EC. Mulder RL, et al. Cochrane Database Syst Rev. 2012 Dec 12;12:CD006300. doi: 10.1002/14651858.CD006300.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2015 Sep 30;(9):CD006300. doi: 10.1002/14651858.CD006300.pub4. PMID: 23235629 Updated. Review.

10

Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study.

Mulder RL, Knijnenburg SL, Geskus RB, van Dalen EC, van der Pal HJ, Koning CC, Bouts AH, Caron HN, Kremer LC. Mulder RL, et al. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1736-46. doi: 10.1158/1055-9965.EPI-13-0036. Epub 2013 Sep 24. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 24064520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters